Outcomes of surgery and subsequent therapy for central nervous system oligoprogression in EGFR-mutated NSCLC patients

Oligoprogression is an emerging issue in patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC). However, the surgical treatment for central nervous system (CNS) oligo...

Source: World Journal of Surgical Oncology - November 25, 2023 Category: Cancer & Oncology Authors: Pang-Shuo Perng, Heng-Juei Hsu, Jung-Shun Lee, Liang-Chao Wang, Chih-Yuan Huang, Chih-Hao Tien, Yu-Hsuan Lai, Po-Lan Su, Hao-Hsiang Hsu, Liang-Yi Chen and Po-Hsuan Lee Tags: Research Source Type: research